(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4,5-trifluorophenyl)propanoic acid is a non-natural, fluorinated phenylalanine derivative protected with a 9-fluorenylmethoxycarbonyl (Fmoc) group on the amino function. It is a chiral building block featuring a 2,4,5-trifluorophenyl side chain. This compound is primarily used as a specialized amino acid building block in solid-phase peptide synthesis (SPPS). The Fmoc protecting group is standard for this methodology, allowing for orthogonal deprotection under mild basic conditions. The incorporation of the trifluorinated aromatic ring into peptide sequences is a common strategy in medicinal chemistry to enhance metabolic stability, modulate lipophilicity, and improve binding affinity to target proteins, particularly in the development of peptide-based therapeutics and probes. Its specific application is as a key intermediate in the synthesis of complex peptides, including those targeting GLP-1 receptors and other biological targets where fluorination is beneficial. It is a high-value research chemical supplied to pharmaceutical and biotech research laboratories.